{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:58:02Z","timestamp":1790740682944,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/md.0b013e3181f2b824","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T07:01:57Z","timestamp":1283929317000},"page":"331-336","source":"Crossref","is-referenced-by-count":43,"title":["The Spectrum of Invasive Pneumococcal Disease at an Adult Tertiary Care Hospital in the Early 21st Century"],"prefix":"10.1097","volume":"89","author":[{"given":"Adriana M.","family":"Rueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Matloobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahwish","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Musher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210309","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/518149","article-title":"Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.","volume":"44","author":"Albrich","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R3-7-20210309","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/dkp210","article-title":"Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.","volume":"64","author":"Ardanuy","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R4-7-20210309","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-60-5-759","article-title":"Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia.","volume":"60","author":"Austrian","year":"1964","journal-title":"Ann Intern Med"},{"key":"R5-7-20210309","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R6-7-20210309","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1371\/journal.ppat.0030168","article-title":"Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.","volume":"3","author":"Brueggemann","year":"2007","journal-title":"PLoS Pathog"},{"key":"R7-7-20210309","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/clinids\/7.2.133","article-title":"Invasive pneumococcal infections: incidence, predisposing factors, and prognosis.","volume":"7","author":"Burman","year":"1985","journal-title":"Rev Infect Dis"},{"key":"R9-7-20210309","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1067\/mlc.2001.119311","article-title":"Bacterial pathogens of otitis media and sinusitis: detection in the nasopharynx with selective agar media.","volume":"138","author":"Dudley","year":"2001","journal-title":"J Lab Clin Med"},{"key":"R11-7-20210309","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"R12-7-20210309","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/IAI.01126-07","article-title":"Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis.","volume":"76","author":"Glover","year":"2008","journal-title":"Infect Immun"},{"key":"R13-7-20210309","first-page":"378","article-title":"Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.","volume":"66","author":"Hak","year":"2008","journal-title":"Neth J Med"},{"key":"R14-7-20210309","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archinte.160.1.89","article-title":"Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy.","volume":"160","author":"Harrison","year":"2000","journal-title":"Arch Intern Med"},{"key":"R16-7-20210309","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"R17-7-20210309","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.vaccine.2009.01.127","article-title":"Invasive pneumococcal disease in the Netherlands: syndromes, outcome and potential vaccine benefits.","volume":"27","author":"Jansen","year":"2009","journal-title":"Vaccine"},{"key":"R18-7-20210309","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/14760584.5.5.651","article-title":"Nasopharyngeal colonization: a target for pneumococcal vaccination.","volume":"5","author":"Kayhty","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"R19-7-20210309","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/599827","article-title":"Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.","volume":"49","author":"Kellner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R20-7-20210309","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2334-8-96","article-title":"Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies.","volume":"8","author":"Klemets","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R21-7-20210309","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1473-3099(02)00450-4","article-title":"Pathogenesis and pathophysiology of pneumococcal meningitis.","volume":"2","author":"Koedel","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"R23-7-20210309","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(80)90460-X","article-title":"Parapneumonic effusions.","volume":"69","author":"Light","year":"1980","journal-title":"Am J Med"},{"key":"R24-7-20210309","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1378\/chest.108.6.1608","article-title":"Bacteremic pneumococcal pneumonia. A community hospital experience.","volume":"108","author":"Lippmann","year":"1995","journal-title":"Chest"},{"issue":"Suppl 2","key":"R25-7-20210309","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"R26-7-20210309","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults.","author":"Moberley","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-7-20210309","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1017\/S0950268808001301","article-title":"Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.","volume":"137","author":"Motlova","year":"2009","journal-title":"Epidemiol Infect"},{"key":"R28-7-20210309","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1001\/jama.1982.03330120044028","article-title":"Pneumococcal disease in a medium-sized community in the United States.","volume":"248","author":"Mufson","year":"1982","journal-title":"JAMA"},{"key":"R30-7-20210309","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-200007000-00002","article-title":"Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study.","volume":"79","author":"Musher","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R31-7-20210309","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1001\/archinte.161.21.2538","article-title":"A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics.","volume":"161","author":"Musher","year":"2001","journal-title":"Arch Intern Med"},{"key":"R32-7-20210309","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/161.4.728","article-title":"Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide.","volume":"161","author":"Musher","year":"1990","journal-title":"J Infect Dis"},{"key":"R33-7-20210309","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.","volume":"201","author":"Musher","year":"2010","journal-title":"J Infect Dis"},{"key":"R34-7-20210309","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/315697","article-title":"Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.","volume":"182","author":"Musher","year":"2000","journal-title":"J Infect Dis"},{"key":"R35-7-20210309","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1172\/JCI36759","article-title":"Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.","volume":"119","author":"Orihuela","year":"2009","journal-title":"J Clin Invest"},{"key":"R36-7-20210309","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/jama.1983.03330260032027","article-title":"Pneumococcal pneumonia in hospitalized patients. Clinical and radiological presentations.","volume":"249","author":"Ort","year":"1983","journal-title":"JAMA"},{"key":"R37-7-20210309","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JCM.44.1.124-131.2006","article-title":"Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates.","volume":"44","author":"Pai","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R38-7-20210309","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neulet.2008.11.070","article-title":"The C-type lectin CD209b is expressed on microglia and it mediates the uptake of capsular polysaccharides of Streptococcus pneumoniae.","volume":"450","author":"Park","year":"2009","journal-title":"Neurosci Lett"},{"key":"R39-7-20210309","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/513635","article-title":"Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin.","volume":"24","author":"Raz","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R40-7-20210309","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.vaccine.2008.11.098","article-title":"Immunological responses to pneumococcal vaccine in frail older people.","volume":"27","author":"Ridda","year":"2009","journal-title":"Vaccine"},{"key":"R41-7-20210309","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R42-7-20210309","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1086\/345954","article-title":"Pneumococcal septic arthritis: review of 190 cases.","volume":"36","author":"Ross","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R43-7-20210309","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1086\/592970","article-title":"Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study.","volume":"47","author":"Tsigrelis","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R44-7-20210309","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181f2b824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:40:51Z","timestamp":1786041651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201009000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181f2b824","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}